Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-12

Clinical Trial Update: Use of Fish Oils to Prevent Atrial Mechanical Stunning and Atrial Remodeling Due to Atrial Arrhythmia [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing whether fish oils (omega-3 fatty acids) can prevent atrial mechanical stunning and remodeling due to atrial arrhythmias in atri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fish oil

Snippet

Sponsor: Melbourne Health | Conditions: Atrial Fibrillation, Atrial Flutter | Phase 4 | Status: COMPLETED